Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 10, 2009, Pages 989-994

  Kesecioglu, Jozef ^a   Beale, Richard ^b   Stewart, Thomas E ^c   Findlay, George P ^d   Rouby, Jean Jacques ^e   Holzapfel, Laurent ^f   Bruins, Peter ^g   Steenken, Edmee J ^h   Jeppesen, Ole K ^h   Lachmann, Burkhard ⁱ  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f CENTRE HOSPITALIER   (France)

^g ST ANTONIUS HOSPITAL   (Netherlands)

^h LEO PHARMA A S   (Denmark)

ⁱ HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Intensive care units; Pulmonary ventilation

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; HL 10; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVERSE OUTCOME; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOTENSION; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MULTICENTER STUDY; OXYGEN SATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACUTE LUNG INJURY; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 72849140957     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200812-1955OC     Document Type: Article

References (25)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2:319-323.
2. Ware LB,Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349.
3. Ranieri VM, Giunta F, Suter PM, Slutsky AS. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 2000;284:43-44. (Pubitemid 30445657)
4. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-1308.
5. Seeger W, Gunther A, Walmrath HD, Grimminger F, Lasch HG. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. Clin Investig 1993;71:177-190.
6. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA III, Hudson LD, Maunder RJ, Crim C, Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-1981.
7. Jobe AH. Pulmonary surfactant therapy. N Engl JMed 1993;328:861-868.
8. Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, Jefferson LS, Conaway MR, Egan EA; Pediatric Acute Lung Injury and Sepsis Investigators. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005;293:470-476.
9. Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventós AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996;334:1417-1421.
10. Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351:884-892.
11. Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, Moxley MA, Cai GZ, Hite RD, Smith RM, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:1309-1315. (Pubitemid 27172776)
12. Kesecioglu J, Schultz MJ, Lundberg D, Lauven PM, Lachmann B. Treatment of acute lung injury (ALI/ARDS) with surfactant [abstract]. Am J Respir Crit Care Med 2001;163:A819.
13. Kesecioglu J, Schultz MJ, Maas JJ, De Wilde RB, Steenken EJ, Lachmann B. Treatment of acute lung injury and ARDS with surfactant is safe [abstract]. Am J Respir Crit Care Med 2004;169: A349.
14. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-824. (Pubitemid 24082248)
15. Meade MO. Pro/con clinical debate: it is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility. Con: the hazards of stopping for futility. Crit Care 2005;9: 34-36.
16. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338:347-354. (Pubitemid 28083906)
17. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, Mazer CD, McLean RF, Rogovein TS, Schouten BD, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med 1998;338:355-361. (Pubitemid 28083907)
18. Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, Fernandez-Mondéjar E, Clémenti E, Mancebo J, Factor P, Matamis D, et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 1998;158:1831-1838.
19. Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P Jr, Wiener CM, Teeter JG, Dodd-o JM, Almog Y, Piantadosi S. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999;27:1492-1498. (Pubitemid 29406938)
20. Esteban A, Anzueto A, Frutos F, Alía I, Brochard L, Stewart TE, Benito S, Epstein SK, Apezteguía C, Nightingale P, et al.; Mechanical Ventilation International Study Group. Mechanical Ventilation International Study Group. Characteristics and outcomes in adult patients receiving mechanical ventilation. JAMA 2002;287:345-355.
21. Suchyta M, Morris AH, Thompson T. Attributes and outcomes of randomized vs excluded patients in ALI/ARDS clinical trials [abstract]. Am J Respir Crit Care Med 2000;161:A210.
22. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome. A randomized controlled trial. JAMA 1999;282:54-61.
23. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351:327-336.
24. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-1693. (Pubitemid 41464707)
25. Ferguson ND, Kacmarek RM, Chiche JD, Singh JM, Hallett DC, Mehta S, Stewart TE. Screening of ARDS patients using standardized ventilator settings: influence on enrollment in a clinical trial. Intensive Care Med 2004;30:1111-1116. (Pubitemid 38833363)